ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 37101566

Well-Defined Heparin Mimetics Can Inhibit Binding of the Trimeric Spike of SARS-CoV-2 in a Length-Dependent Manner.

Sun L and 6 others. JACS Au, 2023. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Well-Defined Heparin Mimetics Can Inhibit Binding of the Trimeric Spike of SARS-CoV-2 in a Length-Dependent Manner. Papers, record 37101566. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37101566

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Well-Defined Heparin Mimetics Can Inhibit Binding of the Trimeric Spike of SARS-CoV-2 in a Length-Dependent Manner.
PubMed
Journal
JACS Au
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2023-04-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun LLifenghttps://orcid.org/0000-0003-4735-954X
2Chopra PPradeephttps://orcid.org/0000-0002-6003-4574
3Tomris IIlhan
4van der Woude RRoosmarijn
5Liu LLinhttps://orcid.org/0000-0002-0310-5946
6de Vries RPRobert Phttps://orcid.org/0000-0002-1586-4464
7Boons GJGeert-Janhttps://orcid.org/0000-0003-3111-5954

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119,756,580In vitro synthesis of heparosan using recombinant Pasteurella multocida heparosan synthase PmHS2.Appl Microbiol Biotechnol2010https://conductscience.org/library/papers/19756580PubMed
224,038,939Tailored design and synthesis of heparan sulfate oligosaccharide analogues using sequential one-pot multienzyme systems.Angew Chem Int Ed Engl2013https://conductscience.org/library/papers/24038939PubMed
333,173,010Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.J Virol2021https://conductscience.org/library/papers/33173010PubMed
430,271,699Impact of Temperature on Heparin and Protein Interactions.Biochem Physiol2018https://conductscience.org/library/papers/30271699PubMed
528,651,046Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.J Am Chem Soc2017https://conductscience.org/library/papers/28651046PubMed
634,786,180On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein.ACS Med Chem Lett2021https://conductscience.org/library/papers/34786180PubMed
719,034,645A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins.Glycoconj J2009https://conductscience.org/library/papers/19034645PubMed
832,653,452Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.Antiviral Res2020https://conductscience.org/library/papers/32653452PubMed
919,943,299Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation.Angew Chem Int Ed Engl2009https://conductscience.org/library/papers/19943299PubMed
1022,894,336Quantifying the rebinding effect in multivalent chemical ligand-receptor systems.J Chem Phys2012https://conductscience.org/library/papers/22894336PubMed

1 to 10 of 45

See all 45 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
41,892,030Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research.Biosensors (Basel)2026https://conductscience.org/library/papers/41892030PubMed
41,513,808K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming.Npj Viruses2026https://conductscience.org/library/papers/41513808PubMed
40,619,669Controlling the Sulfation Density of Glycosaminoglycan Glycopolymer Mimetics Enables High Antiviral Activity against SARS-CoV-2 and Reduces Anticoagulant Activity.Biomacromolecules2025https://conductscience.org/library/papers/40619669PubMed
40,613,236Low-Background His-Tag-Targeting Probes for Turn-On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions.Small2025https://conductscience.org/library/papers/40613236PubMed
39,754,757Recent Advances in Synthetic Strategies of Glycans and their Pharmaceutical Applications.Curr Med Chem2025https://conductscience.org/library/papers/39754757PubMed
39,401,361The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/39401361PubMed
39,199,298Significance of Artificial Intelligence in the Study of Virus-Host Cell Interactions.Biomolecules2024https://conductscience.org/library/papers/39199298PubMed
38,710,572Seaweed-derived fucoidans and rhamnan sulfates serve as potent anti-SARS-CoV-2 agents with potential for prophylaxis.Carbohydr Polym2024https://conductscience.org/library/papers/38710572PubMed
38,203,849Block Synthesis and Step-Growth Polymerization of C-6-Sulfonatomethyl-Containing Sulfated Malto-Oligosaccharides and Their Biological Profiling.Int J Mol Sci2024https://conductscience.org/library/papers/38203849PubMed
37,849,547Heparan Sulfate-Mimicking Glycopolymers Bind SARS-CoV-2 Spike Protein in a Length- and Sulfation Pattern-Dependent Manner.ACS Med Chem Lett2023https://conductscience.org/library/papers/37849547PubMed

1 to 10 of 12

See all 12 cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
A4GNT51,146PubTator's text mininghttps://conductscience.org/library/genes/51146NCBI Gene
ACE259,272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
CTSS1,520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
F102,159PubTator's text mininghttps://conductscience.org/library/genes/2159NCBI Gene
F22,147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
FGF22,247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
PF45,196PubTator's text mininghttps://conductscience.org/library/genes/5196NCBI Gene
SERPINC1462PubTator's text mininghttps://conductscience.org/library/genes/462NCBI Gene
TMPRSS27,113PubTator's text mininghttps://conductscience.org/library/genes/7113NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37101566

GET https://conductscience.org/api/papers/v1/37101566/references?page=2

API referenceFor AI assistants